METAP2 and obesity due to melanocortin 4 receptor deficiency: Understanding the tissue-specific roles of MetAP2 and its alterations in metabolic diseases offers insights into potential therapeutic strategies targeting this enzyme to alleviate obesity, improve glucose homeostasis, and mitigate complications associated with T2DM.